Status:
RECRUITING
Percutaneous Blockade of the Stellate Ganglion in Electrical Storm
Lead Sponsor:
University of Sao Paulo General Hospital
Conditions:
Electrical Storm
Stellate Ganglion Block
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
There is no randomized clinical study in the literature that evaluated the efficacy and safety of the stellate ganglion infiltration procedure in patients with electrical storm. So far, case reports a...
Detailed Description
The study aims to evaluate the reduction of arrhythmic events following stellate ganglion blockade in patients with electrical storm refractory to initial clinical measures. Hypothesis Stellate gangl...
Eligibility Criteria
Inclusion
- Patients over 18 years old with structural heart disease and a diagnosis of refractory electrical storm, or those who require discontinuation of antiarrhythmics due to adverse events or contraindications to standard therapy.
Exclusion
- Patients under 18
- History of heart transplant or prior cardiac denervation surgery
- Anatomical contraindications for the procedure (prior neck surgery, burns, large scars, or thyroid goiter).
- Genetically related polymorphic VT
- End-stage renal disease on dialysis
Key Trial Info
Start Date :
June 6 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT07211347
Start Date
June 6 2025
End Date
December 1 2028
Last Update
October 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research Center of the Heart Institute - University of São Paulo
São Paulo, São Paulo, Brazil, 05409011